Case-Based Roundtable™

Investigator Perspectives

This case-based article and video series explores recent perspectives on treatment strategies around clinical case profiles.


Using Immunotherapy Combinations in Hepatocellular Carcinoma

December 22nd 2022

This roundtable series reviews immunotherapy in patients with unresectable hepatocellular carcinoma as first-line treatment, as discussed by key opinion leaders and participants at virtual live events.

Patients With BTC Eligible for First-Line Chemoimmunotherapy

December 19th 2022

This roundtable series evaluates the use of frontline immunotherapy plus chemotherapy in locally advanced or metastatic biliary tract cancer, as discussed by key opinion leaders and participants at virtual live events.

Targeted Therapy Options for Patients With KRAS-Mutated NSCLC

December 7th 2022

This roundtable series provides context on the growing number of options for patients with non–small cell lung cancer and KRAS G12C mutations, as discussed by key opinion leaders and participants at virtual live events.

Treating Relapsed/Refractory Multiple Myeloma With Bispecific Therapy

November 23rd 2022

This roundtable series assesses later-line treatment of patientswith relapsed/refractory multiple myeloma, as discussed by key opinion leaders and participants at virtual live events.

Combination Immunotherapy and Chemotherapy Used in GI Cancers

October 31st 2022

This roundtable series explores combination treatments for patients with upper gastrointestinal cancer, as discussed by key opinion leaders and participants at virtual live events.

How to Recognize, Diagnose, and Treat Patients With BPDCN

September 28th 2022

This roundtable series discusses blastic plasmacytoid dendritic cell neoplasms in patients and the ways to identify and provide therapy for this rare disease, as discussed by key opinion leaders and participants at virtual live events.

Sequencing for Metastatic Clear Cell Renal Cell Carcinoma After Prior Therapy

September 16th 2022

This roundtable series considers multiple therapies from published clinical trials for patients with relapsed/refractory metastatic clear cell renal cell carcinoma, as discussed by key opinion leaders and participants at virtual live events.

Management and Treatment of Patients With Exon 20 Non–Small Cell Lung Cancer

September 14th 2022

This roundtable series reviews molecular testing in non–small cell lung cancer and potential treatments for patients with EGFR exon 20 mutations, as discussed by key opinion leaders and participants at virtual live events.

Experts Discuss the RCC Landscape and Available Therapy for Patients

September 13th 2022

This roundtable series provides insights on assessing patients with renal cell carcinoma and how to treat them in the first line based on their risk factors, as discussed by experts in video interviews with Targeted Oncology.

Later-Line Options for Patients With PSMA-Positive mCRPC

July 25th 2022

This roundtable series evaluates radioligand therapy in patients with previously treated metastatic castration-resistant prostate cancer with positive prostate-specific membrane antigen, as discussed by participants at virtual live events.